In neurodegenerative diseases, including Alzheimer’s and Parkinson’s diseases, NF-κB activation may contribute to neuronal death and degeneration by promoting oxidative stress and inflammation [20,21]. Here, NFKB1 is linked to neurodegenerative disease.